OncoResponse Revenue and Competitors
Estimated Revenue & Valuation
- OncoResponse's estimated annual revenue is currently $3.7M per year.
- OncoResponse's estimated revenue per employee is $81,600
Employee Data
- OncoResponse has 45 Employees.
OncoResponse's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
OncoResponse Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.9M | 204 | -6% | N/A | N/A |
#2 | $0.2M | 4 | 33% | N/A | N/A |
#3 | $5M | 54 | 0% | N/A | N/A |
#4 | $2.1M | 29 | 0% | N/A | N/A |
#5 | $9.2M | 83 | 32% | N/A | N/A |
#6 | $10.9M | 99 | 27% | N/A | N/A |
#7 | $0.1M | 2 | 0% | N/A | N/A |
#8 | $0.4M | 16 | -58% | N/A | N/A |
#9 | $4.8M | 52 | -7% | N/A | N/A |
#10 | $995.5M | 6971 | 8% | N/A | N/A |
What Is OncoResponse?
OncoResponse leverages the power of the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer. Through our partnership with MD Anderson Cancer Center, we deploy a unique and transformative approach to the discovery of cancer therapeutics. OncoResponse is based in Seattle, Washington.
keywords:N/AN/A
Total Funding
45
Number of Employees
$3.7M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
OncoResponse News
2022-03-22 - OncoResponse Announces Oral Presentation at Festival of ...
OncoResponse is a clinical-stage, immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.4M | 45 | 0% | $116M |
#2 | $11.1M | 45 | -21% | $91.1M |
#3 | $5M | 45 | 2% | N/A |
#4 | $9M | 45 | 7% | N/A |
#5 | $5.5M | 45 | 61% | $20M |